Search
for
Sort by
Research 91–120 of 1000+
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- PA13 A hair’s breadth from misdiagnosis
- Assessment Of the Relation of Serum Adiponectin Level With Alopecia Areata
- Alopecia Areata in Children: Quality of Life for Children and Their Parents
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- Study of Skin Microbiome in Patients with Alopecia Areata: Case Control Study
- Comparison of Efficacy of Platelet Rich Plasma with Intralesional Triamcinolone in the treatment of Alopecia Areata
- Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata
- Topical therapy and skin care for transplant‐associated atopic dermatitis in children and adolescents
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- Could red and near-infrared emitting fabric technology improve the severity of psoriasis, polymorphous light eruption, and alopecia areata?
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Assessment of Vitamin D Level in Patients of Alopecia Areata
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Table 1_Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study.docx
- Evaluation of association of vitamin D in alopecia areata: A case–control study of 100 patients in a tertiary rural hospital of Southern India
- Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study
- Using disease symptomatology to guide treatment in patients with central centrifugal cicatricial alopecia: introduction of C-CAT scoring tool
- Scoring systems for pemphigus
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants